Bioxytran, Inc. is a U.S.-based clinical-stage biotechnology company focused on developing innovative therapies for hypoxia-related conditions, viral infections, and degenerative diseases. The company leverages advanced carbohydrate-based drug design and galectin inhibitor technology to create treatments aimed at stroke, wound healing, and infectious diseases like COVID-19. Its pipeline includes promising drug candidates such as oxygen-carrying therapeutics, antiviral agents and anti-metastasis for cancer designed to address critical unmet medical needs and improve patient outcomes.
-
1 المنشورات
-
1 الصور
-
0 الفيديوهات
-
يعيش في Needham
-
من Needham
-
متابَع بواسطة 0 أشخاص
البحث
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
